首页 > 市场调查报告书 > 製药

药物开发

药物发现资讯学市场规模、份额和成长分析（按功能、应用、解决方案、最终用户和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1897939

药物发现资讯学市场规模、份额和成长分析（按功能、应用、解决方案、最终用户和地区划分）—产业预测，2026-2033年

Drug Discovery Informatics Market Size, Share, and Growth Analysis, By Function (Sequencing and Target Data Analysis, Docking), By Application (Drug Discovery, Drug Development), By Solution, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球药物发现资讯学市场预计到 2024 年将达到 36.6 亿美元，到 2025 年将达到 40.7 亿美元，到 2033 年将达到 95.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 11.3%。

全球药物发现资讯学市场正经历显着成长，这主要得益于对罕见疾病和孤儿药研发的日益重视，以及生物技术和製药业对资讯投入的不断增加。研发支出的激增表明市场对药物发现资讯学的强劲需求，包括製药公司利用综合药物和化合物资料库进行广泛的数据收集。先进的软体能够实现高效的资料库管理和分析，从而应对药物发现过程中的各种挑战。高效能运算、增强的云端服务以及资讯学软体的应用进一步推动了市场扩张。儘管对新型疗法的需求不断增长以及In Silico模拟技术的应用是积极的驱动因素，但资讯学工具的高成本构成了潜在的障碍。然而，发展中地区生物技术的蓬勃发展带来了宝贵的机会。

全球药物发现资讯学市场驱动因素

全球药物发现资讯学市场的发展主要得益于技术的显着进步，尤其是在人工智慧 (AI) 和机器学习领域。这些创新提升了数据分析能力，使研究人员能够有效率且精准地管理大量数据。这种效率的提升显着简化了适用于药物开发的分子实体的识别，并加速了整个药物发现过程。借助这些最尖端科技，研究人员可以做出更明智的决策，推动创新，最终带来更有效的治疗方法和更优质的医疗保健。这些技术的融合标誌着药物发现方式的转捩点，并将彻底改变药物发现的进行方式。

全球药物发现资讯学市场面临的限制因素

全球药物研发资讯学市场面临的主要挑战之一是对资料保护的重视以及遵守各项法律法规的必要性。遵守诸如GDPR等隐私法规使得重要研究资料的管理和共用变得复杂。这种法规环境阻碍了研究人员之间的有效合作，并限制了创新资讯学解决方案的应用。因此，严格的资料保护措施阻碍了药物研发活动的进展，最终抑制了产业成长，并降低了企业投资该领域新技术的动机。

全球药物发现资讯学市场趋势

全球药物研发资讯学市场正呈现出显着趋势，这主要得益于人工智慧和机器学习技术的日益普及。这些先进工具正在革新数据分析，能够更快地识别候选药物并增强预测建模能力。这种变革不仅加速了药物研发进程，也推动了产业的创新和效率提升。随着各机构利用这些技术，他们能够简化工作流程、降低成本并改善团队合作，最终重塑药物研发格局。在竞争日益激烈的市场中，强大的运算能力和数据驱动的洞察力正成为企业成功的关键因素。

IBM（United States）
Infosys Limited（India）
Thermo Fisher Scientific（United States）
PerkinElmer Inc.（United States）
Schrodinger, Inc.（United States）
Charles River Laboratories International, Inc.（United States）
Certara, Inc.（United States）
Accenture plc（Ireland）
Agilent Technologies, Inc.（United States）
Illumina, Inc.（United States）
Dassault Systemes SE（France）
Collaborative Drug Discovery, Inc.（United States）
Eurofins DiscoverX Products（United States）
Jubilant Biosys Limited（India）
Selvita SA（Poland）
Novo Informatics Pvt. Ltd.（India）
ChemAxon Ltd.（Hungary）
Albany Molecular Research Inc.（United States）
Boehringer Ingelheim GmbH（Germany）
Oracle Corporation（United States）

结论与建议

简介目录

Product Code: SQMIG35I2209

Global Drug Discovery Informatics Market size was valued at USD 3.66 Billion in 2024 and is poised to grow from USD 4.07 Billion in 2025 to USD 9.59 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The global drug discovery informatics market is witnessing significant growth driven by the rising focus on rare diseases and orphan drug development, alongside increased investment in informatics by biotechnology and pharmaceutical sectors. This surge in research spending indicates robust demand for drug discovery informatics, which encompasses extensive data gathering facilitated by comprehensive medication and compound databases utilized by pharmaceutical companies. Advanced software enables efficient database management and analysis, addressing various challenges within the discovery process. Enhancements in high-performance computing, cloud services, and the use of informatics software are further propelling market expansion. Increasing demand for novel therapeutic agents and the adoption of in silico modeling technologies contribute positively, while the high costs of informatics tools present potential barriers. However, the growth of biotechnology in developing regions presents valuable opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segments Analysis

Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Informatics Market

The global drug discovery informatics market is being propelled by significant technological advancements, especially in artificial intelligence and machine learning. These innovations enhance data analysis capabilities, enabling researchers to efficiently manage vast amounts of data with remarkable accuracy. This efficiency significantly streamlines the identification of molecular entities suitable for drug development, thereby expediting the overall drug discovery process. As researchers harness these cutting-edge technologies, they can make more informed decisions and drive innovation, ultimately leading to more effective therapies and improved healthcare outcomes. The integration of these technologies marks a transformative shift in how drug discovery is conducted.

Restraints in the Global Drug Discovery Informatics Market

One significant challenge facing the global drug discovery informatics market is the emphasis on data protection and the necessity to adhere to various legal requirements. Compliance with privacy regulations, such as GDPR, complicates the management and sharing of crucial research data. This regulatory environment hampers researchers' ability to collaborate effectively and limits the adoption of innovative informatics solutions. Consequently, the stringent data protection measures pose barriers to progress in drug discovery efforts, ultimately stifling growth and reducing companies' willingness to invest in new technological advancements in this field.

Market Trends of the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market is witnessing a significant trend driven by the increasing adoption of AI and Machine Learning technologies. These advanced tools are revolutionizing data analysis, enabling faster identification of drug candidates and enhancing predictive modeling capabilities. This shift not only accelerates the drug discovery process but also stimulates innovation and efficiency within the industry. As organizations leverage these technologies, they are able to streamline workflows, reduce costs, and improve collaboration across teams, ultimately reshaping the landscape of pharmaceutical research and development. The enhanced computational power and data-driven insights are becoming essential for success in an increasingly competitive market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Patent Analysis

Global Drug Discovery Informatics Market Size by Function & CAGR (2026-2033)

Market Overview
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Other functions

Global Drug Discovery Informatics Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Drug Development
- Preclinical Testing
- Clinical Trials

Global Drug Discovery Informatics Market Size by Solution & CAGR (2026-2033)

Market Overview
Software
Services

Global Drug Discovery Informatics Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Other End Users

Global Drug Discovery Informatics Market Size & CAGR (2026-2033)

North America (Function, Application, Solution, End User)
- US
- Canada
Europe (Function, Application, Solution, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Function, Application, Solution, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Function, Application, Solution, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Function, Application, Solution, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

IBM (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schrodinger, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Certara, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accenture plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dassault Systemes SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collaborative Drug Discovery, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins DiscoverX Products (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Biosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Informatics Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemAxon Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Albany Molecular Research Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments